Format

Send to

Choose Destination
J Invest Dermatol. 2016 Sep;136(9):1920-1924. doi: 10.1016/j.jid.2016.05.110. Epub 2016 Jun 9.

MEK Is a Therapeutic and Chemopreventative Target in Squamous Cell Carcinoma.

Author information

1
Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
2
Department of Molecular & Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
3
Department of Dermatology, Jefferson University, Philadelphia, Pennsylvania, USA.
4
Centre Molecular Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, Scotland.
5
Jacqui Wood Cancer Centre, University of Dundee, Ninewells Hospital and Medical School, Dundee, Scotland.
6
Department of Molecular Biology, Baylor College of Medicine, Houston, Texas, USA.
7
Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: kytsai@mdanderson.org.
PMID:
27293029
PMCID:
PMC5303342
[Available on 2017-03-01]
DOI:
10.1016/j.jid.2016.05.110
[Indexed for MEDLINE]
Free PMC Article

Conflict of interest statement

There are no relevant conflicts of interest.

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center